Literature DB >> 6531951

Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population.

G A Tannock, D A Bryce, M J Hensley, N A Saunders, R S Gillett, W S Kennedy.   

Abstract

A trial with a trivalent influenza subunit vaccine prepared with sodium deoxycholate was carried out in 88 volunteers between May and November 1981. Each haemagglutinin antigen was present at 7 micrograms per dose. Fourfold or greater haemagglutination inhibition antibody (HI) responses to the H1N1 virus A/Brazil/11/78 occurred in 70% of volunteers following a single dose. For the H3N2 virus A/Bangkok/1/79 and B/Singapore/222/79 these figures were 52 and 11%, respectively. No increase in the antibody titre was noted to any of the antigens following a second vaccination dose. Antibody levels remained relatively constant six months after vaccination. A response to B/Singapore/222/79, comparable with the HI response for the influenza A antigens, was noted when serum titres were estimated by a plaque reduction procedure. No neuraminidase inhibition antibody could be detected in response to either A/Brazil/11/78 or A/Bangkok/1/79. No reactions specifically attributable to the vaccine occurred after either injection. A lower HI response to A/Brazil/11/78 was noted in volunteers 52 years of age and older, who also showed less evidence of earlier priming to this virus. Levels of nasal wash neutralizing antibodies to A/Brazil/11/78 were proportional to those detected in sera by HI tests, but were present in smaller amounts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6531951     DOI: 10.1016/s0264-410x(98)90040-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Evaluation of Mycoplasma inactivation during production of biologics: egg-based viral vaccines as a model.

Authors:  Selwyn A Wilson David; Dmitriy V Volokhov; Zhiping Ye; Vladimir Chizhikov
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

Review 2.  Prevention of influenza in the general population.

Authors:  Joanne M Langley; Marie E Faughnan
Journal:  CMAJ       Date:  2004-11-09       Impact factor: 8.262

Review 3.  Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis.

Authors:  Andrea C Tricco; Ayman Chit; Charlene Soobiah; David Hallett; Genevieve Meier; Maggie H Chen; Mariam Tashkandi; Chris T Bauch; Mark Loeb
Journal:  BMC Med       Date:  2013-06-25       Impact factor: 8.775

Review 4.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.